Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jonosteril is a sterile, preservative-free isotonic and isoionic electrolyte infusion solution used for parenteral fluid and electrolyte replacement. It is indicated for the treatment of extracellular dehydration, hyponatremia, hypokalemia, hypochloremia, acidosis (including mild acidosis), and for the prophylaxis of dehydration and electrolyte loss in adults as well as pediatric populations. The solution contains various electrolytes—primarily sodium chloride, potassium chloride or acetate, calcium diacetate or chloride, magnesium diacetate or chloride—and acetate salts to help maintain acid-base balance. Its mechanism of action is to restore fluid volume and correct electrolyte imbalances by providing physiologically relevant concentrations of essential ions intravenously[1][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on jonosteril.